Skip to main content
. 2017 Dec 23;9(2):2678–2696. doi: 10.18632/oncotarget.23626

Table 3. Metabolites differentiating IDC from both benign and controls a) Tissue metabolites, b) Serum metabolites.

S. No Metabolite HMDB ID FC (IDC/C) AUC (IDC/C) FC (IDC/B) AUC (IDC/B)
a) Tissue
1 Histidine HMDB00177 3.28 0.79 2.29 0.64
2 Glutamine HMDB00641 4.60 0.87 2.38 0.73
3 Tyrosine HMDB00158 8.73 0.96 3.19 0.83
4 Creatine HMDB00064 4.32 0.85 2.36 0.72
5 Phenylalanine HMDB00159 3.98 0.92 2.45 0.81
6 Lactic acid HMDB00190 4.35 0.85 2.54 0.76
7 Adonitol HMDB00508 2.22 0.78 1.64 0.70
8 3,7-Cholest-5-ene HMDB00941 0.48 0.81 0.35 0.76
b) Serum
1 Ascorbic acid HMDB00044 0.31 0.98 0.32 0.73
2 Tryptophan HMDB00929 0.49 0.93 0.62 0.78
3 Tyrosine HMDB00158 0.61 0.89 0.68 0.74
4 Phenylalanine HMDB00159 0.57 0.91 0.66 0.76
5 Uric acid HMDB00289 0.60 0.88 0.63 0.79
6 α-Ketoglutaric acid HMDB00208 15.26 0.81 5.14 0.74
7 UDP HMDB00295 0.43 0.91 0.46 0.83
8 Creatine HMDB00064 0.53 0.83 0.63 0.76
9 Pyruvate HMDB00243 0.31 0.85 0.40 0.78

HMDB ID: Metabolite ID obtained from HMDB database, FC: Fold change (FC>1.4), IDC/C: IDC against control, AUC: Area under the curve, IDC/B: IDC against benign.